LEO BROKERAGE, LLC - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 44 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LEO BROKERAGE, LLC ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$16,923
-24.0%
14,8450.0%0.00%
-33.3%
Q1 2023$22,268
-34.5%
14,8450.0%0.00%
-66.7%
Q2 2022$34,0000.0%14,8450.0%0.01%
+80.0%
Q1 2022$34,000
-78.2%
14,8450.0%0.01%
-82.8%
Q3 2021$156,00014,8450.03%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$231,0000.01%
FNY Investment Advisers, LLC 3,500$8,0000.01%
LEO BROKERAGE, LLC 14,845$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 37,900$88,0000.00%
UBS Group AG 13,618$31,0000.00%
RHUMBLINE ADVISERS 16,169$37,0000.00%
Ellevest, Inc. 19$00.00%
TWO SIGMA INVESTMENTS, LP 62,184$144,0000.00%
FMR LLC 179$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 10,375$24,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders